Clinician Scientific & Educational Resources

Non-Hodgkin Lymphoma (NHL) is a classification of malignant neoplasm of the lymphoid tissue that involves white blood cells, specifically, precursors for B and T cells and their mature counterparts. Over time, the disease may progress, metastasize and eventually spread to other organs. The prognosis of NHL varies by its type and stage. Knowledge on latest research and advances in treatment contribute to improved outcomes and quality of life.

Learn more about NHL and who is at risk, challenges, diagnosis and staging, current guidelines, and more about the latest advances in treatment for individualized, multidisciplinary care by exploring different topics within the portal. High-definition animations and other tools can be found in HD Visual Learning.

This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Copyright © 2024 NHL Strive. All Rights Reserved. Website by Divigner

Pin It on Pinterest

Directory
Scroll to Top

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers